Entry |
|
Name |
Intestinal immune network for IgA production - Homo sapiens (human)
|
Description |
The intestine is the largest lymphoid tissue in the body. One striking feature of intestinal immunity is its ability to generate great amounts of noninflammatory immunoglobulin A (IgA) antibodies that serve as the first line of defense against microorganisms. The basic map of IgA production includes induction of mucosal B cells in the Peyer's patches, circulation through the bloodstream and homing to intestinal mucosa of IgA-commited plasma cells, and local antibody production for export across the intestinal membranes. Multiple cytokines, including TGF-{beta}, IL-10, IL-4, IL-5, and IL-6, are required to promote IgA class switching and terminal differentiation process of the B cells. Secreted IgA promotes immune exclusion by entrapping dietary antigens and microorganisms in the mucus and functions for neutralization of toxins and pathogenic microbes.
|
Class |
Organismal Systems; Immune system
|
Pathway map |
hsa04672 | Intestinal immune network for IgA production |

|
Drug |
D10028 | Valategrast hydrochloride (USAN) |
D10379 | Vercirnon sodium (USAN) |
D11348 | Reltecimod sodium (USAN) |
D11556 | Idecabtagene vicleucel (USAN) |
D11907 | Rozibafusp alfa (USAN/INN) |
|
Other DBs |
|
Organism |
Homo sapiens (human) [GN: hsa]
|
Gene |
3108 | HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752] |
3109 | HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752] |
3111 | HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752] |
3112 | HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752] |
3113 | HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752] |
3115 | HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752] |
3117 | HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752] |
3118 | HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752] |
3119 | HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752] |
3122 | HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752] |
3123 | HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752] |
3125 | HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752] |
3126 | HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752] |
3127 | HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752] |
7040 | TGFB1; transforming growth factor beta 1 [KO:K13375] |
8741 | TNFSF13; TNF superfamily member 13 [KO:K05475] |
23495 | TNFRSF13B; TNF receptor superfamily member 13B [KO:K05150] |
608 | TNFRSF17; TNF receptor superfamily member 17 [KO:K05153] |
115650 | TNFRSF13C; TNF receptor superfamily member 13C [KO:K05151] |
23308 | ICOSLG; inducible T cell costimulator ligand [KO:K06710] |
6387 | CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031] |
7852 | CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189] |
2826 | CCR10; C-C motif chemokine receptor 10 [KO:K04185] |
6370 | CCL25; C-C motif chemokine ligand 25 [KO:K13072] |
8174 | MADCAM1; mucosal vascular addressin cell adhesion molecule 1 [KO:K06779] |
3601 | IL15RA; interleukin 15 receptor subunit alpha [KO:K05074] |
5284 | PIGR; polymeric immunoglobulin receptor [KO:K13073] |
|
Compound |
|
Reference |
|
Authors |
Fagarasan S, Honjo T |
Title |
Intestinal IgA synthesis: regulation of front-line body defences. |
Journal |
|
Reference |
|
Authors |
Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P |
Title |
The immune geography of IgA induction and function. |
Journal |
|
Reference |
|
Authors |
Kunisawa J, Kiyono H |
Title |
A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense. |
Journal |
|
Reference |
|
Authors |
Cerutti A, Rescigno M |
Title |
The biology of intestinal immunoglobulin A responses. |
Journal |
|
Reference |
|
Authors |
Tsuji M, Suzuki K, Kinoshita K, Fagarasan S |
Title |
Dynamic interactions between bacteria and immune cells leading to intestinal IgA synthesis. |
Journal |
|
Reference |
|
Authors |
Corthesy B |
Title |
Roundtrip ticket for secretory IgA: role in mucosal homeostasis? |
Journal |
|
Reference |
|
Authors |
Suzuki K, Fagarasan S |
Title |
How host-bacterial interactions lead to IgA synthesis in the gut. |
Journal |
|
Reference |
|
Authors |
Mora JR, von Andrian UH |
Title |
Differentiation and homing of IgA-secreting cells. |
Journal |
|
Reference |
|
Authors |
Suzuki K, Ha SA, Tsuji M, Fagarasan S |
Title |
Intestinal IgA synthesis: a primitive form of adaptive immunity that regulates microbial communities in the gut. |
Journal |
|
Reference |
|
Authors |
Cerutti A |
Title |
The regulation of IgA class switching. |
Journal |
|
Related pathway |
hsa04612 | Antigen processing and presentation |
hsa04660 | T cell receptor signaling pathway |
hsa04662 | B cell receptor signaling pathway |
hsa04670 | Leukocyte transendothelial migration |
|
KO pathway |
|
LinkDB |
|